Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | MGAM | O43451 | 1/20 | 0.36 |
| ▸ | SI | P14410 | 1/20 | 0.36 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.36 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.34 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.34 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethyl Acetate SCHEMBL6338631 | 0.98 | ALDH1A1 (0.58) | ALDH1A1LMNAHSD17B10TSHRTRPA1 | |
| Ethyl Acetate SCHEMBL28814573 | 0.96 | ALDH1A1 (0.56) | ALDH1A1LMNAHSD17B10TSHRTRPA1 | |
| Ethyl Acetate SCHEMBL6064388 | 0.94 | ALDH1A1 (0.58) | ALDH1A1LMNAHSD17B10TSHRTRPA1 | |
| Ethyl Acetate SCHEMBL6347449 | 0.91 | ALDH1A1 (0.74) | ALDH1A1LMNAHSD17B10TSHRTRPA1 | |
| Ethyl Acetate SCHEMBL276158 | 0.91 | ALDH1A1 (0.74) | ALDH1A1LMNAHSD17B10TSHRTRPA1 | |
| Ethyl Acetate SCHEMBL5861342 | 0.91 | ALDH1A1 (0.74) | ALDH1A1LMNAHSD17B10TSHRTRPA1 | |
| Ethyl Acetate SCHEMBL6046507 | 0.91 | ALDH1A1 (0.74) | ALDH1A1LMNAHSD17B10TSHRTRPA1 | |
| Ethyl Acetate SCHEMBL1231 | 0.89 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10TSHRTRPA1 | |
| Ethyl Acetate SCHEMBL11579143 | 0.89 | ALDH1A1 (0.70) | ALDH1A1LMNAHSD17B10TSHRTRPA1 | |
| Ethyl Acetate SCHEMBL3507062 | 0.89 | ALDH1A1 (0.70) | ALDH1A1LMNAHSD17B10TSHRTRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117269403-B | Thin-layer identification method of medicinal material Zanthoxylum bungeanum in Chinese medicinal composition containing Zanthoxylum bungeanum | 湖南易能生物医药有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-117269403-A | Thin-layer identification method of medicinal material Zanthoxylum bungeanum in Chinese medicinal composition containing Zanthoxylum bungeanum | 湖南易能生物医药有限公司 | 2023-12-22 | — | — | CN | disclosed |
| US-8293715-B2 | 10a-Azalide compound crosslinked at 10a- and 12-positions | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2012-10-23 | — | — | US | disclosed |
| US-20110237784-A1 | 10A-AZALIDE COMPOUND CROSSLINKED AT 10A- AND 12-POSITIONS | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2011-09-29 | — | — | US | disclosed |
| EP-2177526-A1 | 10A-AZALIDE COMPOUND CROSSLINKED AT POSITION-10A AND POSITION-12 | Taisho Pharmaceutical Co. Ltd. (JP) | 2010-04-21 | — | — | EP | disclosed |
| EP-1212096-A2 | DRUG CONJUGATES AND METHODS OF DESIGNING THE SAME | Brenner, Sydney (US) | 2002-06-12 | — | — | EP | disclosed |
| WO-2001013958-A2 | DRUG CONJUGATES AND METHODS OF DESIGNING THE SAME | BRENNER SYDNEY (US) | 2001-03-01 | — | — | WO | disclosed |
| US-5476931-A | Reacting with a base in a mixed solvent containing alcohol | RIKAGAKU KENKYUSHO (JP) | 1995-12-19 | — | — | US | disclosed |
| EP-0311694-B1 | NUCLEOSIDE DERIVATIVES AND PROCESS FOR THEIR PREPARATION | RIKAGAKU KENKYUSHO (JP) | 1995-12-13 | — | — | EP | disclosed |
| US-5380722-A | Antiarrhythmia agents | ROUSSEL-UCLAF (FR) | 1995-01-10 | — | — | US | disclosed |
| US-5208234-A | Hypotensive | E. R. SQUIBB & SONS, INC. (US) | 1993-05-04 | — | — | US | disclosed |
| US-5208235-A | Phosphonic or phosphinic acid derivatives as inhibitors of angiotnesin II for cardiovascular disorders and hypotensives | E. R. SQUIBB & SONS, INC. (US) | 1993-05-04 | — | — | US | disclosed |
| US-5144018-A | Antiviral Agents | RIKAGAKU KENKYUSHO (JP) | 1992-09-01 | — | — | US | disclosed |
| US-4908367-A | Antiarrythmic agents | Uclaf, Roussel (FR) | 1990-03-13 | — | — | US | disclosed |
| EP-0311694-A1 | NUCLEOSIDE DERIVATIVES AND PROCESS FOR THEIR PREPARATION | RIKAGAKU KENKYUSHO (JP) | 1989-04-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110237784-A1 | 10A-AZALIDE COMPOUND CROSSLINKED AT 10A- AND 12-POSITIONS | DCLRE1A, AZI2, CHD9 | ALDH1A1 2376/4885LMNA 1834/4885HSD17B10 267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.